RAM Essential Services Property Fund (REP) Earnings Call Transcript & Summary
August 26, 2026
Earnings Call Speaker Segments
Operator
operatorAt this point I'd like to turn the call over to Scott Kelly, our Managing Director and Group CEO. Scott, please go ahead.
Scott Kelly
unknownThanks so much, Ryan, and morning to everyone. You just heard it — I'm Scott Kelly, Group CEO at Real Asset Management. With me today are George Websdale, our Head of Real Estate, Doug Rapson, who leads Listed Real Estate, and Chang Liu, Fund Manager on REP. What we'll do is spend the next 20 minutes walking through the presentation we posted this morning, and then we'll have some time to wrap up with Q&A. If you go to page 2, that's the agenda. I'll cover the highlights, then pass it to Doug, who will take you through the transaction's key components. Chang will walk you through the portfolio as at 30 June, and George will cover the financial numbers and the strategy going forward. Over on page 4. The headline item sits at the top right: we've reached an unconditional sale of the five retail assets, bringing in more than $200 million for the fund and accounting for slightly over a third of its assets. Settlement is expected in Q2 FY 2027. So a key focus of this presentation will be our next steps.
Scott Kelly
unknownWith that said, we still have the usual set of figures to give you an update on the portfolio. On leasing, we completed 21 deals during the period, with average spreads of 4%. The weighted average rent review is 3.5%, and 56% of the leases are on a net basis, which gives protection against cost inflation. 84% of those leases carry fixed increases or CPI-linked reviews, and after the transaction the WALE will extend to 8.1 years, reflecting the greater healthcare weighting. It's also worth noting there are no arrears on our private hospital exposure. Income was reduced last quarter, as George will cover, but you could argue that's not surprising given rates have risen three times in the last 6 months. Even so, that income level still equates to an attractive yield. Following the transaction, gearing will be 16.8%. As that debt comes down, the hedging will simply be adjusted in lockstep. As at 30 June, 61% of the debt was hedged. Our stated strategy was to become a specialized REIT focused on healthcare. This transaction gets us there and gives us the capacity to make accretive acquisitions in our chosen sector. However, we're very aware that we're sitting on a significant discount.
Scott Kelly
unknownThat isn't uncommon in this kind of market. Apart from Goodman, 95% of the REITs on the ASX are trading at a discount. What that means is we're actively looking at every option for the fund as we go forward, and George will touch on that. With that said, I'll pass things over to Doug.
Doug Rapson
unknownThanks, Scott. If we move to page 5. After the fund's late-July announcement and the mid-August follow-up, we can now confirm that contracts for selling the five retail assets have exchanged unconditionally. The divested assets are Coomera Square, Springfield Fair, Coles Rutherford, Tanilba Bay Plaza, and Mowbray Marketplace. A newly established fund with a major institutional investor has acquired them. Net realized value from the retail assets came to $218.6 million, and proceeds consist of cash plus a 10% equity interest in the new fund. That interest gives REP unitholders continued exposure to the income and benefits of the retail assets. Importantly, the deal was done direct, with REP paying no acquisition or divestment fees. No broker fees were paid either. As for the fund structure, it is a discrete five-asset fund with a 5-year investment term and a minimum 2-year hold. Because it is discrete, REP has no forecast requirement to allocate additional capital for further acquisitions. The fund's targeted distribution is 5.5% to 6% per annum. This marks a major milestone in REP's strategic transition to a healthcare-focused portfolio. Chang will walk through the changes to fund composition before and after the transaction in detail during the portfolio performance section.
Doug Rapson
unknownBut I wanted to briefly highlight a few important metrics. WALE is set to rise by 1.3 years, which gives us longer, more dependable cash flow. Healthcare income is up 21%, and tertiary healthcare income from private hospitals is up 17%. Higher forecast income will fuel future net property growth, through more leases with CPI and fixed annual escalators, along with an increase in net leases. If you turn to page 6, on why we're shifting toward a healthcare focus. The investment case for healthcare — which we laid out when the strategy transition to a specialized healthcare fund was announced — is still strong. Management has confidence in the strategic advantages of moving to healthcare. On demographics, Australia's population is growing. Crucially for healthcare, it is also growing and aging, with the over-65 cohort rising at 2% over the next 30 years to reach roughly 8 million people by 2051. As this large cohort keeps aging, demand for healthcare services will grow in both the public and private sectors. Government expenditure keeps rising at both state and federal level, growing at 3.4% over the last 10 years. There's also been substantial investment into emerging services, including mental health.
Doug Rapson
unknownRoughly 45% of Australians have private health insurance. The strength of private health coverage will keep underpinning demand for these services and sustain usage in the private setting. Lastly, the distinctive occupier environment and lease structure offer considerable advantages, including: both the operator and landlord commit substantial investment to constructing and fitting out healthcare assets, alongside the time and investment operators put into securing key staff and contracts. To mitigate risk and get suitable payback from that time and investment, operators generally look to sign long-term leases. That gives the fund an ongoing, stable income stream. A large share of rent reviews linked to CPI drives solid income growth when inflation stays higher for longer. Lease structures are mostly triple net, with outgoings borne by the tenant. That offers a natural hedge against expenditure increases caused by inflation. Furthermore, longer leases and the triple net lease structure usually mean less capital expenditure on incentives and building works, plus lower repairs and maintenance costs across the assets. When debt costs are elevated, being able to limit capital assigned to investment that is not income- or value-accretive is critical. I'll now hand over to Chang, who will step through the portfolio performance.
Chang Liu
unknownThanks, Doug. If we turn to page 8, the portfolio summary. I'll start with an overview and the key metrics for the portfolio as of 30 June 2026, and then walk through how the recently announced deals will substantially reshape the fund. Just to reiterate, those transactions include the five retail assets along with two smaller, non-core, low-yielding medical assets — Mildura and Rosebery. Let's begin with the portfolio metrics as at 30 June. The fund holds 26 properties — 19 medical and seven retail — with a combined total property value of $662.6 million. The weighted average cap rate is 6.2%. Occupancy is steady at 70 97%. Across the portfolio there is more than 110,000 square meters of lettable area and 234 tenants. The two charts at the top show tenant mix and income exposure, which demonstrate the quality of the income across our portfolio. On the tenant mix side, 98% of the portfolio consists of essential service-based tenants, which highlights the strength of the tenant covenant. Within that 98%, 43% is essential retail and nearly 55% is healthcare. Importantly, 26% of that comes from tertiary healthcare, which is mostly income from private hospitals. Non-essential exposure is only under 2%. I'd also point out the small share of discretionary tenants in our portfolio, which holds obvious appeal in this environment.
Chang Liu
unknownWhen it comes to income exposure, 84% of what we receive is exposed to annual escalations. About 58% is fixed, 26% is linked to CPI, and 15% is formula-based. If inflation moderates, that fixed share delivers reliable growth, while the CPI portion provides upside should inflation come in hotter than anticipated. All told, the blended weighted average rent review was 3.5%. Let's now examine these numbers after the transactions. The portfolio ends up with 19 assets — two retail assets, Punchbowl Plaza and Ballina Central, plus the other 17, which are medical assets. Following the transactions, the fund metrics shift materially in four key respects. First, healthcare income rises by 21 percentage points, reaching 74% post-transactions, with income from tertiary healthcare in particular set to account for 43% of the total portfolio — an increase of 17 percentage points. Second, WALE extends from 6.8 years to 8.1 years, largely driven by the longer lease tenure of our healthcare tenants. On top of that, a further 7% of lease expiries will shift beyond FY 2031. As more expiries move into the final bar, the expiry profile shown at the bottom of this page will become flatter in the near years. Third, income quality improves.
Chang Liu
unknownIncome tied to fixed reviews and CPI is set to rise 8 percentage points, moving up from the 84% figure shown here. Net lease arrangements will climb 3% as well, reaching close to 60%. What that means is greater contracted growth, and tenants will carry more of the outgoings risk. And finally, gearing drops significantly, to 16.8% upon settlement, and George will go through that in greater detail on the slides coming later. Let's now turn to page 9, valuations. Within the past 3 months, 96% of the portfolio has been externally valued, which stacks up well against our peers and gives us confidence in our valuation and, as a result, our NTA. The weighted average cap rate has moved out 11 basis points since December 2025, going from 6.09% to 6.2%, as we flagged in the highlights. The waterfall on the left side is fairly straightforward. We started at a book value of $675.5 million. Capex and other fair value adjustments came in quite neutral. All told, valuation movements totaled $12.5 million, which reflects that 11-bips cap rate expansion. Book value then ended at $662.6 million as of 30 June 2026. That amounts to a modest decline of under 2% over the half year. With that, I'll pass things to George to walk through our financial performance.
George Websdale
unknownThanks, Chang. I'll now turn to slide 11. For the fund, FY 2026 was a year of consolidation and transition, and that shows up in FFO of $14.7 million, which is $9.8 million below FY 2025. The main reason for the shift in FFO across the two periods is income forgone from asset sales, one-off income recognized in FY 2025, along with other non-recurring items incurred in FY 2026. On a pleasing note, like-for-like property income rose 4.4% to $38 million, and underlying FFO increased by a slightly smaller 4.1% to 14.6 $17.6 million, reflecting the effect of higher financing costs. Distributions paid during the year came to 4.55 cents, versus 5 cents in FY 2025. Moving to slide 12 and the balance sheet: gearing rose in the period to 43.5%, reflecting softer valuations and a decline in the value of assets held for sale or sold during the period. That said, once the retail transaction settles, which Scott noted is expected in the second quarter of FY 2027, gearing falls significantly to 16.8%, and borrowings drop from $267 million to $75 million. Hedging across the portfolio was kept at around 60%, and following the transaction we're working with our treasury team on short-term and medium-term financing strategies, with preliminary lender support received to refinance the facility after settlement.
George Websdale
unknownLower debt leaves the fund’s balance sheet well placed and steady for FY 2027. Turning now to slide 14 and what lies ahead. FY 2027 guidance: DPU per security is projected at 3.6 to 3.8 cents per unit, on the assumption of an FFO payout ratio of 90% to 100%. With securities trading where they currently are, that gives investors a yield of 8.5% to 9%, and 90% of the distribution is tax-deferred. Moving to slide 15 now. The central question is where we go from here, and what can the fund do to maximise value for investors? Completing the retail transaction makes the fund a healthcare-focused REIT with low gearing, a stable income base, a better portfolio, a longer WALE, and embedded value-add opportunities. Management will keep actively managing the existing portfolio to draw out value for unitholders. That said, as management had anticipated, this ought to be the moment for the fund to capitalise on the high-quality healthcare acquisition opportunities emerging in the market. That said, it is plainly not something we can do, since deploying capital into accretive acquisitions is unrealistic while we keep trading at a deep discount to NTA. Although the retail sales reset the fund’s balance sheet and leave the portfolio positioned to deliver repeatable, stable income going forward, negative sentiment towards small-cap REITs and towards the fund makes it hard to expect the NTA trading gap to narrow materially in the near term.
George Websdale
unknownSo management is going to keep actively looking at and pursuing other ways to handle capital. One possibility is restarting the on-market buyback. The financial metrics there are compelling, but because the stock has limited liquidity, carrying out a meaningful buyback is difficult. Another possibility could be an off-market buyback and take-private. That said, it needs a new capital partner or partners who back the healthcare strategy. We're also looking at a progressive sell-down of the fund's assets, which would return capital. But the on-market depth of capital for healthcare is still thin, and an orderly sell-down takes a long timeframe, which means liquidity in the stock will probably be even lower. As we examine each option, our focus will be on maximizing investor value, speed of execution, and giving investors investment optionality. With that, I'll hand back to Scott to wrap up.
Scott Kelly
unknownThanks, George. If you go to page 17, I'll give you a quick summary. Our underlying portfolio is still resilient. Occupancy levels are high, and rental income streams continue to grow, whether through how the leases are structured or when they come up for renewal. Inflation protection is still robust, both because most leases are on a net basis and because 84% have either CPI linkage or a fixed yearly rent increase. Nearly every asset was revalued quite recently, which gives us solid and precise valuations. We told you we've transitioned to a specialized REIT with roughly 80% weighting to healthcare, and the transaction we've announced essentially brings us to that weighting. Now that we're there, our initial plan was to capture the considerable market opportunity to buy well-priced medical assets. We'll have the dry powder for that, since we'll end up at 16.8% gearing. That said, we have to acknowledge that rates have been climbing, and REP, like nearly every REIT on the ASX, trades at a significant discount. So we need to weigh every possible option, with the clear aim of maximizing value for unitholders, and that's what we're actively doing. With that, I'm happy to take questions.
Operator
operatorThank you. Should you want to pose a question, kindly press *1 on your phone and hold until your name is called. To withdraw your request, just press *2. In case you're using a speakerphone, please lift the handset before asking your question. Our first question comes from Cody Shield of UBS. Please go ahead.
Cody Shield
unknownMorning, everyone, and thanks for joining us today. So, I'm just trying to get a sense of how we ought to be thinking about the coming 12 to 18 months. You're clearly saying that a few different pathways for the fund are under consideration, and it might take some time to get there. You mention acquisitions probably aren't the best use of capital and that buybacks are tricky. How should unitholders think about the next 12 months in terms of how some of those proceeds will be deployed while you work through these various options?
George Websdale
unknownNaturally, after we complete the settlement of the transaction, during the next few weeks, we will be weighing all of those alternatives. Clearly, a buyback makes a lot of sense, and it feels like something we have carried out before, and we are examining that. Regarding how the portfolio stands, which clearly is fairly steady at this point, we believe we can deliver those repeatable, stable returns going forward. In the end, where we stand right now is to do everything possible to alter the fund's trajectory and narrow that discount to NTA.
Cody Shield
unknownIf you were to go the buyback route, what sort of size would you be looking to put to work?
Scott Kelly
unknownI suppose there are a few months still available to us, since the transaction isn't set to close until the end of the year — the end of the calendar year. At that stage, we'll assess where we stand. As I understand it, we are officially the smallest REIT in the market. That constrains liquidity for a standard buyback, so we'll be contemplating a bigger buyback. There are still a few months for us to watch how matters develop. We could find ourselves in a position where the rate cycle has turned, but we are actively weighing most options, though in the end, Cody, it will come down to the maths of the situation at that time.
Cody Shield
unknownUnderstood. Then one final item from me: regarding your distribution guidance of 3.6 to 3.8 cents, is it fair to assume that figure reflects entirely organic growth baked in for FY 2027, with no other initiatives?
George Websdale
unknownThat's right.
Cody Shield
unknownThat’s great. I appreciate it, everyone.
George Websdale
unknownSure thing.
Operator
operatorThanks. The following question is from Jason Taleb at JDT Advisory. You have the floor.
Jason Taleb
unknownWhy keep the 10% position in the retail fund — what's the thinking behind that? And if you decided to exit down the road, is there a way to dispose of it?
George Websdale
unknownObviously, the thinking here is that we see a chance to keep gathering the income from that, and it will give us an accretive yield. We will serve as a partner in that fund, and as we have said, the fund is a 5-year investment vehicle with a 2-year hold. In the medium term, we believe there will be a chance to unlock that. For the fund, we view that as an attractive investment.
Scott Kelly
unknownIf we step back for a moment, the strategy we announced 2 years ago carries an 80% weighting. What was the reason for 80? It comes down to the fact that we remain fond of those assets and want to keep a certain amount of exposure, which provides us with flexibility. Through this holding, we get exposure — clearly a diversified exposure — to five separate assets that we understand well.
Jason Taleb
unknownI appreciate that.
Operator
operatorThank you. As a reminder, should you want to pose a question, dial *1 on your phone and then hold until your name is called. Our next question is from Craig Haskin of Eastern Hill Advisors. You may proceed.
Craig Haskin
unknownHi, guys. Thanks for the presentation. Just a quick one about the buyback. Given the discount to NTA, why do you sort of seem to be hedging your bets on an on-market buyback and liquidity? There's 500, was it 500 million shares on issue, and you guys own 30% of them. Liquidity is a function of the price you pay, and every cent that you spend from here up to 70 cents is accretive to unitholders. I'm not quite sure why you're hedging on a on-market buyback. Further to that, you've been working on this capital transaction, and well done on getting it over the line, for quite some time. What actually has to happen between now and whenever you make some announcement as to what you might do? I assume you've already had quite a bit of time to think about this; it feels a little bit odd that you've announced the transaction, you've cut your distribution back to sort of cash, and now you're sort of hedging your bets on the what's next.
Scott Kelly
unknownI'll take a first stab at that, Craig. We aren't trying to hedge anything. We're simply laying out what the options are. The money doesn't come to us until year-end, and things could shift between now and that point. What we really mean is that a standard on-market buyback gives us limited liquidity. Our point is that we intend to go beyond that. We will aim to do more than that, since that approach won't have much impact. We've tried that in the past, and with the liquidity we have, moving the dial that way is difficult. What we're really telling you is that we're open to doing more, and we're searching for mechanisms to accomplish it. This isn't about hedging. We're just signaling that we're open to every mechanism for a significant buyback, rather than the on-market route, which frankly won't move the dial at all. I don't see it as hedging. We're just flagging that we're open to the full range of options.
Craig Haskin
unknownThanks. Should we be looking to the AGM for a bit more clarity, or is the stock just going to bounce around here, trading on the yield and waiting to see what's next?
Scott Kelly
unknownAs we get nearer to settlement, that approach will of course be firmed up based on the conditions at that moment. If we happen to be at a 40%
Craig Haskin
unknownRegarding the discount—what situations are we talking about? Interest rates have moved back up, and cap rates have moved back up as well. Our income stream is resilient and defensive. At this point, what is the major event? I would welcome being corrected, but what significant operational, financial, or other change is involved here? If your deal is complete and the funds are arriving, that is hedging, because you are hedging your bets. What difference will occur between now and December? Certainly, we might see one or two rate increases. What other major external factor is going to alter what ought to be a fairly straightforward decision equation?
Scott Kelly
unknownThe way we see it, we do anticipate carrying that out, though we first have to be able to provide people with clarity on it. We're signalling openness to it, but, for instance, rates might not rise in the next few months, and we could be facing 2027, when rate cycles turn. The discount may have narrowed by then. Most likely it won't, but we need to reach a position where we have certainty on such matters. We are definitely signalling that we're open to a buyback more significant than an on-market buyback. We simply need to reach that point.
Craig Haskin
unknownIt would help your share price quite a bit if shareholders actually got a bit more clarity than that. Perhaps you could set a target for yourself of making some absolutely definitive announcement at the AGM, which I take it falls around October-November, since you're within cooee of the transaction closing, right?
Scott Kelly
unknownGlad to look at that, Craig. Beyond that, in the event we pursue a sizable buyback, there's a good chance—as George noted—that equity partners would be needed to carry it out. When you consider it, that would likely involve roughly $100 million in equity. Clearly, that's a major part of the puzzle.
Craig Haskin
unknownAppreciate it.
Scott Kelly
unknownThanks.
Operator
operatorThank you. Our next question is from John Powell at Prism Debt Capital Advisory. Please go ahead. John, please unmute your line and proceed with your question. As there is no response, we will move on. If you wish to ask a question, please press *1 on your telephone and wait for your name to be announced. There are no further phone questions at this time. With that, we conclude our conference for today. Thank you for participating. You may now disconnect.
Scott Kelly
unknownThank you, everyone.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete RAM Essential Services Property Fund transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to RAM Essential Services Property Fund earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in RAM Essential Services Property Fund or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.